These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3923626)

  • 1. A cost-benefit analysis of the Quebec Network of Genetic Medicine.
    Dagenais DL; Courville L; Dagenais MG
    Soc Sci Med; 1985; 20(6):601-7. PubMed ID: 3923626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community genetics and dignity in diversity in the Quebec Network of Genetic Medicine.
    Scriver CR
    Community Genet; 2006; 9(3):142-52. PubMed ID: 16741343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic screening: marvel or menace?
    Rowley PT
    Science; 1984 Jul; 225(4658):138-44. PubMed ID: 6729472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neonatal screening in Denmark. Status and future perspectives].
    Simonsen H; Brandt NJ; Nørgaard-Pedersen B
    Ugeskr Laeger; 1998 Sep; 160(40):5777-82. PubMed ID: 9782755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public policy implications of human genetic technology: genetic screening.
    Blank RH
    J Med Philos; 1982 Nov; 7(4):355-74. PubMed ID: 6820957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
    Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
    Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic screening: triumphs, problems, and controversies.
    Natowicz MR; Alper JS
    J Public Health Policy; 1991; 12(4):475-91. PubMed ID: 1802891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of hereditary disorders.
    Porter IH
    Annu Rev Public Health; 1982; 3():277-319. PubMed ID: 6756430
    [No Abstract]   [Full Text] [Related]  

  • 9. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
    Delatycki MB
    Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism].
    Gu X; Wang J; Ye J; Cheng X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):147-9. PubMed ID: 11860921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shaping priorities in genetic medicine.
    Boyle PJ
    Hastings Cent Rep; 1995; 25(3 Suppl):S2-8. PubMed ID: 11654187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Judaism, genetic screening and genetic therapy.
    Rosner F
    Mt Sinai J Med; 1998; 65(5-6):406-13. PubMed ID: 9844372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems in the control of genetic disorders.
    Kuliev AM; Modell B
    Biomed Sci; 1990 Jan; 1(1):3-17. PubMed ID: 2130914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population screening for genetic disorders in California.
    Kaback MM
    UCLA Forum Med Sci; 1978; 20():207-19. PubMed ID: 80863
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
    Geelhoed EA; Lewis B; Hounsome D; O'leary P
    J Paediatr Child Health; 2005 Nov; 41(11):575-9. PubMed ID: 16398841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
    Lew RM; Burnett L; Proos AL; Barlow-Stewart K; Delatycki MB; Bankier A; Aizenberg H; Field MJ; Berman Y; Fleischer R; Fietz M
    J Paediatr Child Health; 2015 Mar; 51(3):271-9. PubMed ID: 24923490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit analysis of a prenatal preventive programme against congenital syphilis.
    Stray-Pedersen B
    NIPH Ann; 1980 May; 3(1):57-66. PubMed ID: 6779243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.?
    Ross LF
    J Law Med Ethics; 2006; 34(4):753-64. PubMed ID: 17199818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost/benefit study of the neonatal detection of phenylketonuria and hypothyroidism].
    Dhondt JL; Farriaux JP; Lebrun T; Sailly JC
    Pediatrie; 1988; 43(4):345-8. PubMed ID: 3138627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic returns to community and hospital screening programs for a genetic disease.
    Swint JM; Shapiro JM; Corson VL; Reynolds LW; Thomas GH; Kazazian HH
    Prev Med; 1979 Jul; 8(4):463-70. PubMed ID: 112594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.